Lozol Related Published Studies
Well-designed clinical trials related to Lozol (Indapamide)
Large volume injection of 1-octanol as sample diluent in reversed phase liquid chromatography: application in bioanalysis for assaying of indapamide in whole blood. [2011.04.05]
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. [2010.12]
Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected]. [2010.07]
Combination therapy with angiotensin-converting enzyme inhibitors and indapamide impairs glucose tolerance in Chinese hypertensive patients. [2010.04]
Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension. [2009.12]
Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients. [2009.05]
Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments. [2009.05]
Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments. [2008.12.15]
Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE. [2008.06]
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. [2007.09.08]
Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes. [2007.01]
Indapamide decreases plasma adiponectin concentration in patients with essential hypertension. [2007]
Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy. [2007]
Simple, sensitive and rapid LC-MS method for the quantitation of indapamide in human plasma--application to pharmacokinetic studies. [2006.09.14]
Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study. [2006.01]
Rapid and sensitive determination of indapamide in human blood by liquid chromatography with electrospray ionization mass spectrometric detection: application to a bioequivalence study. [2005.11]
Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. [2005.11]
Evaluation of long-term efficacy and acceptability of indapamide SR in elderly hypertensive patients. [2005.01]
Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach. [2004.12]
Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. [2004.08]
Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. [2004.08]
Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study. [2004.08]
Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry. [2004.05]
Effects of a low dose of indapamide, a diuretic, given daily or every-other-day on blood pressure and metabolic parameters. [2004.03]
Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study. [2004.03]
Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. [2004.01.07]
Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy. [2003.09]
Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes. [2003.08]
[Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment] [2003.07]
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. [2003.05.12]
Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. [2003.05]
Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial. [2003.03]
Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study. [2003.02]
[Combination of low-dose perindopril/indapamide versus atenolol in the hypertensive patient. Effects on systolic pressure and arterial hemodynamics. REASON Study] [2002.09]
Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design. [2002.09]
Gender influence on the dose-ranging of a low-dose perindopril-indapamide combination in hypertension: effect on systolic and pulse pressure. [2002.08]
Comparison of indapamide and low-dose hydrochlorothiazide monotherapy in black patients with mild to moderate hypertension. [2002.07]
Fixed combinations of delapril plus indapamide vs fosinopril plus hydrochlorothiazide in mild to moderate essential hypertension. [2002.05]
Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension. [2001.11]
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination. [2001.11]
Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. [2001.10]
Antihypertensive efficacy and tolerability of low-dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension. [2001.05]
A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study. [2001.02]
Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. [2000.10]
Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison. [2000.03]
Pharmacokinetics of sustained and immediate release formulations of indapamide after single and repeated oral administration in healthy volunteers. [2000.03]
Fixed low-dose combination therapy in hypertension--a dose response study of perindopril and indapamide. [2000.03]
Efficacy and safety of a fixed low-dose perindopril/indapamide combination in essential hypertension. A randomised controlled study. [2000.01]
Efficacy and safety of an oral fixed low-dose perindopril 2 MG/indapamide 0.625 MG combination: a randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension. [1999.10]
[Study on the antidiuretic efficacy and mechanism of indapamide in central diabetes insipidus] [1999]
Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group. [1998.11]
Twenty-four hour antihypertensive efficacy of indapamide, 1.5-mg sustained release: results of two randomized double-blind controlled studies. [1998.10]
Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension. [1997.04]
[Treatment of hypertension with indapamide 1.5 mg sustained-release form: synthesis of results] [1996.09]
Indapamide (Natrilix): the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria. [1996.08]
Indapamide is as effective as captopril in the control of microalbuminuria in diabetes. [1996.03]
Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria. [1996.02.22]
Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. [1996.02.22]
Indapamide regresses, but transdermal clonidine does not regress, left ventricular hypertrophy in hypertensive diabetic patients. [1996.02.22]
An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension. [1995.12]
[Therapeutic benefit of a low dose of indapamide: results of a double-blind against placebo European controlled study] [1995.08]
Conversion from 2.5 mg to 1.25 mg indapamide in patients with mild to moderate hypertension. [1995.07]
Efficacious response with lower dose indapamide therapy in the treatment of elderly patients with mild to moderate hypertension. [1995.01]
Comparison between the effects of indapamide and hydrochlorothiazide on creatinine clearance in patients with impaired renal function and hypertension. [1995]
Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. [1993]
Regression of microalbuminuria: results of a controlled study, indapamide versus captopril. [1993]
Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study. [1993]
A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide. [1991.08]
Comparison of indapamide and hydrochlorothiazide plus amiloride as a third drug in the treatment of arterial hypertension. [1989.04]
Effect of indapamide on serum and red cell cations, with and without magnesium supplementation, in subjects with mild hypertension. [1988.09.17]
Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide. [1988.01.29]
Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension. [1988.01]
Well-designed clinical trials possibly related to Lozol (Indapamide)
The Hypertension in the Very Elderly Trial - latest data. [2013]
Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study. [2011.08]
Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs. [2011.04]
Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. [2010.11.30]
Monitoring adherence to medication by measuring change in blood pressure. [2010.10]
Modelling cognitive decline in the Hypertension in the Very Elderly Trial [HYVET] and proposed risk tables for population use. [2010.07.26]
Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET). [2010.07]
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial. [2010.06]
The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. [2010.05]
Efficacy and safety of diuretics in combination with perindopril in hypertensive stroke patients: Results of the Japan Perindopril and Diuretics on Cerebrovascular Disease Study (J-PADOC). [2010.02]
Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. [2010.02]
Early increase in autoantibodies against human oxidized low-density lipoprotein in hypertensive patients after blood pressure control. [2010.02]
Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial. [2010.02]
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature. [2009.11]
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. [2009.11]
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature. [2009.10.02]
Mixed models showed no need for initial response monitoring after starting antihypertensive therapy. [2009.06]
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. [2009.05]
Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial. [2009.04.30]
Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis. [2009.04]
Lowering blood pressure reduces renal events in type 2 diabetes. [2009.04]
Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study. [2009.02.03]
An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event. [2009.02]
Older age should not be a barrier to the treatment of hypertension. [2008.09]
Older age should not be a barrier to the treatment of hypertension. [2008.07.08]
Treatment of hypertension in patients 80 years of age or older. [2008.05.01]
Comparison of monotherapy versus combination antihypertensive therapy in elderly patients with essential hypertension. [2008.04]
Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. [2008.03]
[Advanced credit: patient enrolling and therapy initiation in the ADVANCE trial.] [2007.09.30]
|
